FIRSTSUN CAPITAL BAN ($FSUN) posted quarterly earnings results for Q4 2025 on Monday, January 26th. The company reported earnings of $0.95 per share, beating estimates of $0.86 by $0.09. The company also reported revenue of $111,360,000, beating estimates of $109,763,985 by $1,596,015.
You can see Quiver Quantitative's $FSUN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
FIRSTSUN CAPITAL BAN Hedge Fund Activity
We have seen 66 institutional investors add shares of FIRSTSUN CAPITAL BAN stock to their portfolio, and 33 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO removed 634,038 shares (-63.1%) from their portfolio in Q3 2025, for an estimated $24,594,334
- STATE STREET CORP added 278,018 shares (+162.0%) to their portfolio in Q3 2025, for an estimated $10,784,318
- STIEVEN CAPITAL ADVISORS, L.P. removed 190,995 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $7,408,696
- HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC added 172,658 shares (+inf%) to their portfolio in Q3 2025, for an estimated $6,697,403
- AQR CAPITAL MANAGEMENT LLC added 160,162 shares (+inf%) to their portfolio in Q3 2025, for an estimated $6,212,683
- TWO SIGMA INVESTMENTS, LP added 99,196 shares (+96.7%) to their portfolio in Q3 2025, for an estimated $3,847,812
- MARSHALL WACE, LLP removed 94,105 shares (-77.7%) from their portfolio in Q3 2025, for an estimated $3,650,332
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
FIRSTSUN CAPITAL BAN Analyst Ratings
Wall Street analysts have issued reports on $FSUN in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Keefe, Bruyette & Woods issued a "Outperform" rating on 11/05/2025
To track analyst ratings and price targets for FIRSTSUN CAPITAL BAN, check out Quiver Quantitative's $FSUN forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
